Clinical Review

Gastric Electric Stimulation for Refractory Gastroparesis


 

References

Device migration/flipping most often occurs because the device is inadequately fixed to the underlying fascia, but occasionally it can occur from patients flipping the device around. Flipping can occur due to superficial pocket location within subcutaneous tissue, especially in obese patients. Migration/flipping can lead to prominence of the contour of the device and discomfort, ultimately requiring surgical correction.

Small bowel obstruction caused by wrapping of the small bowel loops around the stimulator leads.

Perforation and erosion of the leads. With time, leads can erode into the stomach, although this is rare. Usually erosion is associated with loss of device function. Endoscopy confirms this finding. In rare cases, infection can track proximally along the lead and present as a surgical site infection at the pulse generator. This complication often requires explantation of the neurostimulator leads and pulse generator.

Placement of the device in left upper quadrant, with leads coiled under the generator in the pocket.

Intestinal obstruction. Although rare, the intestines can get wrapped around the leads of the device, causing different degrees of obstruction (Figure 1). Positioning the device in the left upper quadrant minimizes the intraabdominal length of the leads and pulls them maximally out, coiling under the device (Figure 2). In cases where other locations are used either due to a hostile upper abdominal region (skin infection, presence of gastrostomy or other devices) or surgeon’s preference, the GES device can be implanted in the lower abdomen (Figure 3). In these circumstances, carefully draping the omentum over the bowels might help to prevent this complication. Tacking of the leads to the parietal peritoneum with sutures can also be preventative. In cases of obstruction requiring intervention by laparotomy or minimal access techniques (laparoscopy or robotic assisted surgery), all efforts are made to preserve the neurostimulator leads. In cases that require bowel resection, lead contamination is a serious concern, but lead explantation is not mandatory. Close postoperative monitoring for the development of lead infection is required.

Placement of the device in right lower quadrant with the long intraabdominal course of the leads visualized.

Hematoma and seroma. Postoperative hematomas can occur from inadequate hemostasis, and seromas can occur in the stimulator pocket. Small hematomas may be observed if not complicated (Figure 4). In cases of large hematomas with skin compromise or dehiscence, prompt washout and drainage is required. In ideal cases, the device can be preserved. Relocation to another site might be required if skin necrosis develops. The possibility of device contamination also must be considered; after resolution of wound issues, implantation of a new device may be tried. Seromas at the generator pocket site are a frequent occurrence but are often benign, self-limiting, and generally resolve over 4 to 6 weeks.

Hematoma at the site of the gastric electric stimulator implantation.

Incisional hernia. Hernias can develop after any abdominal surgery and are not unique to GES implantation. Use of minimally invasive technique for the GES implantation minimizes this complication.

Pages

Recommended Reading

Study investigates statin-diabetes link
Journal of Clinical Outcomes Management
New diabetes guidelines downgrade insulin as first-line injectable treatment
Journal of Clinical Outcomes Management
Active migraine in women linked to lower risk of developing T2DM
Journal of Clinical Outcomes Management
New risk-prediction model for diabetes under development
Journal of Clinical Outcomes Management
‘Payoff will be great’ if we can conquer childhood obesity, expert says
Journal of Clinical Outcomes Management
New diabetes drugs solidify their cardiovascular and renal benefits
Journal of Clinical Outcomes Management
Researchers exploring ways to mitigate aging’s impact on diabetes
Journal of Clinical Outcomes Management
Torrent Pharmaceuticals expands losartan recall
Journal of Clinical Outcomes Management
Does reduced degradation of insulin by the liver cause type 2 diabetes?
Journal of Clinical Outcomes Management
SGLT-2 inhibitors promising for heart failure prevention, not treatment
Journal of Clinical Outcomes Management